Bowel cancer drug funding in danger

drugs2

As many as 6,500 bowel cancer patients could be denied access to life-extending drugs when a cash pot to pay for them ceases to exist at the end of the year, a charity has warned.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here